PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportshyponatremia
MeSH D007010 - hyponatremia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D014883:Water-electrolyte imbalance
1 Company
1 Drug
$
Success rate
D007010: 
Hyponatremia
9 Companies
2 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Accord HealthcareTolvaptan Tolvaptan Accord     
Alkem LaboratoriesTolvaptan Tolvaptan  2020-05-19   
ApotexTolvaptan Tolvaptan  2020-05-19   
Cumberland PharmaceuticalsConivaptan Vaprisol  2005-12-29 $-0.147 M Q4/22-Q1/24 
EndoTolvaptan Tolvaptan  2022-02-15   
HeteroTolvaptan Tolvaptan  2021-07-16   
Lupin ResearchTolvaptan Tolvaptan  2025-04-23   
MSN LaboratoriesTolvaptan Tolvaptan  2023-06-21   
OtsukaTolvaptan Jinarc  2015-05-27   
Tolvaptan Jynarque 2026-09-01 2018-04-23   
Tolvaptan Samsca 2026-09-01 2009-05-19   
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
100%
4/4
Phase 3
40%
6/15
Approved: 2Overall Success rate: 40%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Cumberland Pharmaceuticals
Conivaptan,
Bevifimod,
Ym087
Otsuka
Tolvaptan,
Sodium chloride
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use